Key result
Stigma in primary progressive multiple sclerosis linked to ~13% greater odds of concurrent depression.
Why the study?
Limited information is available on the presence and impact of stigma in patients with primary progressive multiple sclerosis.
Does stigma impact quality of life and mood in patients with primary progressive multiple sclerosis?
Cross-Sectional (n=55)
Does stigma impact quality of life and mood in patients with primary progressive multiple sclerosis?
Odds Ratio: 1.13
p-value: p=0.046
Stigma is highly prevalent in patients with primary progressive multiple sclerosis and has a detrimental effect on quality of life and mood.
Stigma may warrant assessment in PPMS for concurrent depression risk; leaves open whether interventions targeting stigma improve outcomes.
Stigma associated with neurological disorders may contribute to a poor health-related quality of life. However, limited information is available in primary progressive multiple sclerosis. We investigated the presence and impact of stigma in patients with primary progressive multiple sclerosis. A non-interventional, cross-sectional study was conducted. A total of 55 primary progressive multiple sclerosis patients were studied (mean age 55.8±9.5 years, 56.4% male). The median Expanded Disability Status Scale score was 5.5 (4.0–6.5). Stigma prevalence was 78.2% ( n=43). Twenty-four patients (43.6%) were classified as depressed. Scores on the eight-item Stigma Scale for Chronic Illness correlated with physical (rho=0.464, p<0.001) and psychological (rho=0.358, p=0.007) 29-item Multiple Sclerosis Impact Scale subscores. Stigma predicted concurrent depression (odds ratio=1.13; p=0.046). Stigma was highly prevalent with a detrimental effect on quality of life and mood in primary progressive multiple sclerosis.
No takes yet. Share an insight, caveat, or question.
Pérez‐Miralles et al. (2019) conducted a cross-sectional in Primary progressive multiple sclerosis (n=55). Stigma was evaluated on Concurrent depression (OR 1.13, p=0.046). Stigma was highly prevalent (78.2%) in patients with primary progressive multiple sclerosis and significantly predicted concurrent depression (OR 1.13, p=0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: